BlackRock’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-812,398
Closed -$124K 5618
2023
Q2
$124K Sell
812,398
-212,922
-21% -$33.1K ﹤0.01% 4854
2023
Q1
$147K Buy
1,025,320
+79,142
+8% +$12.7K ﹤0.01% 4871
2022
Q4
$114K Buy
946,178
+740
+0.1% +$107 ﹤0.01% 4998
2022
Q3
$170K Sell
945,438
-4,156
-0.4% -$2.24K ﹤0.01% 5019
2022
Q2
$1.68M Sell
949,594
-2,417,421
-72% -$5.43M ﹤0.01% 4321
2022
Q1
$10.1M Buy
3,367,015
+23,215
+0.7% +$62.1K ﹤0.01% 3572
2021
Q4
$12.4M Buy
3,343,800
+249,314
+8% +$1.46M ﹤0.01% 3541
2021
Q3
$18.3M Buy
3,094,486
+56,793
+2% +$798K ﹤0.01% 3339
2021
Q2
$52.8M Buy
3,037,693
+2,245,566
+283% +$40.9M ﹤0.01% 2664
2021
Q1
$15.1M Buy
792,127
+1,525
+0.2% +$27.8K ﹤0.01% 3336
2020
Q4
$13.8M Buy
790,602
+89,662
+13% +$1.07M ﹤0.01% 3203
2020
Q3
$7.46M Buy
+700,940
New +$7.19M ﹤0.01% 3390

Other funds holding HGEN

BlackRock's HGEN Position: Q3 2023 in Review

BlackRock sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 812,398 shares — an estimated $124K sold.

BlackRock first reported a position in HGEN in Q3 2020 and held it in 12 quarters. The position peaked at $52.8M in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

  • BlackRock reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
  • BlackRock sold 812,398 HUMANIGEN, INC. shares in Q3 2023, an estimated $124K.
  • BlackRock first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 12 quarters.
  • BlackRock's HUMANIGEN, INC. position peaked at $52.8M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.